Patents by Inventor David M. Gravett

David M. Gravett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for treating inflammatory conditions utilizing protein or polysaccharide containing anti-microtubule agents
    Publication number: 20030157161
    Abstract: Disclosed herein are compositions and methods for treating a variety of inflammatory conditions (e.g., inflammatory arthritis, adhesions, tumor excision sites, and fibroproliferative diseases of the eye). For example, there is provided a composition comprising a protein or polysaccharide containing dispersed (e.g., in micelle or liposome form) anti-microtubule agent, which may be formulated for administration to a patient in need thereof.
    Type: Application
    Filed: November 6, 2002
    Publication date: August 21, 2003
    Applicant: Angiotech Pharmaceuticals, Inc.
    Inventors: William L. Hunter, David M. Gravett, Richard T. Liggins, Philip M. Toleikis
  • Compositions and methods for treating disease utilizing a combination of radioactive therapy and cell-cycle inhibitors
    Publication number: 20030144570
    Abstract: Disclosed herein are therapeutic devices, compositions and methods for treating proliferative diseases.
    Type: Application
    Filed: May 24, 2002
    Publication date: July 31, 2003
    Applicant: Angiotech Pharmaceuticals, Inc.
    Inventors: William L. Hunter, David M. Gravett, Richard T. Liggins, Troy A.E. Loss, Arpita Maiti, Philip M. Toleikis
  • Compositions and methods for treating inflammatory conditions utilizing protein or polysaccharide containing anti-microtubule agents
    Publication number: 20020192280
    Abstract: Disclosed herein are compositions and methods for treating a variety of inflammatory conditions (e.g., inflammatory arthritis, adhesions, tumor excision sites, and fibroproliferative diseases of the eye). For example, there is provided a composition comprising a protein or polysaccharide containing dispersed (e.g., in micelle or liposome form) anti-microtubule agent, which may be formulated for administration to a patient in need thereof.
    Type: Application
    Filed: May 1, 2002
    Publication date: December 19, 2002
    Applicant: Angiotech Pharmaceuticals, Inc.
    Inventors: William L. Hunter, David M. Gravett, Richard T. Liggins, Philip M. Toleikis
  • Compositions and methods for treating disease utilizing a combination of radioactive therapy and cell-cycle inhibitors
    Publication number: 20020055666
    Abstract: Disclosed herein are therapeutic devices, compositions and methods for treating proliferative diseases.
    Type: Application
    Filed: May 24, 2001
    Publication date: May 9, 2002
    Inventors: William L. Hunter, David M. Gravett, Richard T. Liggins, Troy A.E. Loss, Arpita Maiti, Philip M. Toleikis